In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.” – LACOG | Cancer Research

Articles, Publications

In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”

Gustavo A. Viani, Andre G. Gouveia, Fabio Y. Moraes

DOI: 10.1016/j.radonc.2022.09.017

Full link: https://doi.org/10.1016/j.radonc.2022.09.017